154 related articles for article (PubMed ID: 31243792)
1. Adeno-associated virus (AAV)-mediated neuroprotective effects on the degenerative retina: the therapeutic potential of erythropoietin.
Tao Y; Zhu Q; Wang L; Zha X; Teng D; Xu L
Fundam Clin Pharmacol; 2020 Feb; 34(1):131-147. PubMed ID: 31243792
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous delivery of tauroursodeoxycholic acid rescues the cone photoreceptors in degenerative retina: A promising therapeutic molecule for retinopathy.
Tao Y; Dong X; Lu X; Qu Y; Wang C; Peng G; Zhang J
Biomed Pharmacother; 2019 Sep; 117():109021. PubMed ID: 31387173
[TBL] [Abstract][Full Text] [Related]
3. Photoreceptor degeneration in mice: adeno-associated viral vector-mediated delivery of erythropoietin.
Colella P; Auricchio A
Methods Mol Biol; 2013; 982():237-63. PubMed ID: 23456874
[TBL] [Abstract][Full Text] [Related]
4. Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration.
Rex TS; Allocca M; Domenici L; Surace EM; Maguire AM; Lyubarsky A; Cellerino A; Bennett J; Auricchio A
Mol Ther; 2004 Nov; 10(5):855-61. PubMed ID: 15509503
[TBL] [Abstract][Full Text] [Related]
5. Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration.
Colella P; Iodice C; Di Vicino U; Annunziata I; Surace EM; Auricchio A
Hum Mol Genet; 2011 Jun; 20(11):2251-62. PubMed ID: 21421996
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina.
Grant CA; Ponnazhagan S; Wang XS; Srivastava A; Li T
Curr Eye Res; 1997 Sep; 16(9):949-56. PubMed ID: 9288458
[TBL] [Abstract][Full Text] [Related]
7. Tropisms of AAV for subretinal delivery to the neonatal mouse retina and its application for in vivo rescue of developmental photoreceptor disorders.
Watanabe S; Sanuki R; Ueno S; Koyasu T; Hasegawa T; Furukawa T
PLoS One; 2013; 8(1):e54146. PubMed ID: 23335994
[TBL] [Abstract][Full Text] [Related]
8. Optimized nonionic emulsifier for the efficient delivery of astaxanthin nanodispersions to retina:
Xu L; Yu H; Sun H; Yu X; Tao Y
Drug Deliv; 2019 Dec; 26(1):1222-1234. PubMed ID: 31747793
[TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of erythropoietin rescues the photoreceptors in degenerative retina: a noninvasive method to deliver drugs to the eye.
Tao Y; Li C; Yao A; Qu Y; Qin L; Xiong Z; Zhang J; Wang W
Drug Deliv; 2019 Dec; 26(1):78-88. PubMed ID: 30744451
[TBL] [Abstract][Full Text] [Related]
10. Subretinal delivery of erythropoietin alleviates the N-methyl-N-nitrosourea-induced photoreceptor degeneration and visual functional impairments: an in vivo and ex vivo study.
Tao Y; Wang Y; Ma Z; Wang L; Qin L; Wang L; Huang YF; Zhang S
Drug Deliv; 2017 Nov; 24(1):1273-1283. PubMed ID: 28891332
[TBL] [Abstract][Full Text] [Related]
11. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy.
Xu H; Zhang L; Gu L; Lu L; Gao G; Li W; Xu G; Wang J; Gao F; Xu JY; Yao J; Wang F; Zhang J; Xu GT
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1519-30. PubMed ID: 24508793
[TBL] [Abstract][Full Text] [Related]
12. Rod Outer Segment Development Influences AAV-Mediated Photoreceptor Transduction After Subretinal Injection.
Petit L; Ma S; Cheng SY; Gao G; Punzo C
Hum Gene Ther; 2017 Jun; 28(6):464-481. PubMed ID: 28510482
[TBL] [Abstract][Full Text] [Related]
13. Subretinal gene therapy of mice with Bardet-Biedl syndrome type 1.
Seo S; Mullins RF; Dumitrescu AV; Bhattarai S; Gratie D; Wang K; Stone EM; Sheffield V; Drack AV
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6118-32. PubMed ID: 23900607
[TBL] [Abstract][Full Text] [Related]
14. AAV-mediated Gene Therapy Halts Retinal Degeneration in PDE6β-deficient Dogs.
Pichard V; Provost N; Mendes-Madeira A; Libeau L; Hulin P; Tshilenge KT; Biget M; Ameline B; Deschamps JY; Weber M; Le Meur G; Colle MA; Moullier P; Rolling F
Mol Ther; 2016 May; 24(5):867-76. PubMed ID: 26857842
[TBL] [Abstract][Full Text] [Related]
15. Photoreceptor protection by adeno-associated virus-mediated LEDGF expression in the RCS rat model of retinal degeneration: probing the mechanism.
Raz-Prag D; Zeng Y; Sieving PA; Bush RA
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3897-906. PubMed ID: 19324854
[TBL] [Abstract][Full Text] [Related]
16. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice.
Macé E; Caplette R; Marre O; Sengupta A; Chaffiol A; Barbe P; Desrosiers M; Bamberg E; Sahel JA; Picaud S; Duebel J; Dalkara D
Mol Ther; 2015 Jan; 23(1):7-16. PubMed ID: 25095892
[TBL] [Abstract][Full Text] [Related]
17. Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration.
Jomary C; Vincent KA; Grist J; Neal MJ; Jones SE
Gene Ther; 1997 Jul; 4(7):683-90. PubMed ID: 9282169
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse.
Rex TS; Wong Y; Kodali K; Merry S
Exp Eye Res; 2009 Nov; 89(5):735-40. PubMed ID: 19591826
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus-vectored gene therapy for retinal disease.
Dinculescu A; Glushakova L; Min SH; Hauswirth WW
Hum Gene Ther; 2005 Jun; 16(6):649-63. PubMed ID: 15960597
[TBL] [Abstract][Full Text] [Related]
20. AAV-mediated gene therapy in mouse models of recessive retinal degeneration.
Pang JJ; Lei L; Dai X; Shi W; Liu X; Dinculescu A; McDowell JH
Curr Mol Med; 2012 Mar; 12(3):316-30. PubMed ID: 22300136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
